The Healthcare & Life Sciences (HLS) sector is facing a wide range of major challenges driven by the need to protect current earnings, transform business models (to do more with less) and grow new businesses in related areas. Ongoing challenges include: healthcare compliance, product withdrawals, fraud and counterfeit, espionage and security and the need to demonstrate economic value. All these remain relevant and must be addressed to support and enable safe transformation and growth. Strengthening risk management capabilities and building organisation resilience support success and are essential during change.
|Whether using analytics to predict drug safety issues or creating global commercial compliance frameworks, Deloitte’s David Hodgson highlights some of the approaches being adopted by some of our Healthcare & Life Sciences clients.|